116 related articles for article (PubMed ID: 16189523)
1. No common denominator for breast cancer lymph node metastasis.
Weigelt B; Wessels LF; Bosma AJ; Glas AM; Nuyten DS; He YD; Dai H; Peterse JL; van't Veer LJ
Br J Cancer; 2005 Oct; 93(8):924-32. PubMed ID: 16189523
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients.
Popeda M; Markiewicz A; Stokowy T; Szade J; Niemira M; Kretowski A; Bednarz-Knoll N; Zaczek AJ
Sci Rep; 2021 Mar; 11(1):5097. PubMed ID: 33658651
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis.
Zucchi I; Mento E; Kuznetsov VA; Scotti M; Valsecchi V; Simionati B; Vicinanza E; Valle G; Pilotti S; Reinbold R; Vezzoni P; Albertini A; Dulbecco R
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18147-52. PubMed ID: 15608061
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.
Liu X; Kolokythas A; Wang J; Huang H; Zhou X
Curr Cancer Ther Rev; 2010 Nov; 6(4):294-307. PubMed ID: 21709736
[TBL] [Abstract][Full Text] [Related]
5. Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis.
Arena GO; Forte S; Abdouh M; Vanier C; Corbeil D; Lorico A
Cells; 2023 Jun; 12(12):. PubMed ID: 37371036
[TBL] [Abstract][Full Text] [Related]
6. Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis.
Srour MK; Qu Y; Deng N; Carlson K; Mirocha J; Gao B; Dadmanesh F; Cui X; Giuliano AE
Breast J; 2021 May; 27(5):432-440. PubMed ID: 33464691
[TBL] [Abstract][Full Text] [Related]
7. Concepts of extracellular matrix remodelling in tumour progression and metastasis.
Winkler J; Abisoye-Ogunniyan A; Metcalf KJ; Werb Z
Nat Commun; 2020 Oct; 11(1):5120. PubMed ID: 33037194
[TBL] [Abstract][Full Text] [Related]
8. Differentially Expressed Genes in Matched Normal, Cancer, and Lymph Node Metastases Predict Clinical Outcomes in Patients With Breast Cancer.
Kim GE; Kim NI; Lee JS; Park MH; Kang K
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):111-122. PubMed ID: 32044879
[TBL] [Abstract][Full Text] [Related]
9. Gene expression comparison between primary triple-negative breast cancer and paired axillary and sentinel lymph node metastasis.
Srour MK; Gao B; Dadmanesh F; Carlson K; Qu Y; Deng N; Cui X; Giuliano AE
Breast J; 2020 May; 26(5):904-910. PubMed ID: 31713298
[TBL] [Abstract][Full Text] [Related]
10. Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors.
Mohammed SI; Torres-Luquis O; Walls E; Lloyd F
Mol Oncol; 2019 Jun; 13(6):1400-1418. PubMed ID: 31026363
[TBL] [Abstract][Full Text] [Related]
11. Remodeling the Microenvironment before Occurrence and Metastasis of Cancer.
Zhang X; Xiang J
Int J Biol Sci; 2019; 15(1):105-113. PubMed ID: 30662351
[TBL] [Abstract][Full Text] [Related]
12. The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets.
Buckley BJ; Ali U; Kelso MJ; Ranson M
Curr Drug Targets; 2019; 20(9):970-981. PubMed ID: 30516104
[TBL] [Abstract][Full Text] [Related]
13. Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients.
Chatterjee G; Pai T; Hardiman T; Avery-Kiejda K; Scott RJ; Spencer J; Pinder SE; Grigoriadis A
Breast Cancer Res; 2018 Nov; 20(1):143. PubMed ID: 30458865
[TBL] [Abstract][Full Text] [Related]
14. An extracellular matrix-related prognostic and predictive indicator for early-stage non-small cell lung cancer.
Lim SB; Tan SJ; Lim WT; Lim CT
Nat Commun; 2017 Nov; 8(1):1734. PubMed ID: 29170406
[TBL] [Abstract][Full Text] [Related]
15. P-cadherin: a useful biomarker for axillary-based breast cancer decisions in the clinical practice.
Vieira AF; Dionísio MR; Gomes M; Cameselle-Teijeiro JF; Lacerda M; Amendoeira I; Schmitt F; Paredes J
Mod Pathol; 2017 May; 30(5):698-709. PubMed ID: 28084338
[TBL] [Abstract][Full Text] [Related]
16. Inherent variability of cancer-specific aneuploidy generates metastases.
Bloomfield M; Duesberg P
Mol Cytogenet; 2016; 9():90. PubMed ID: 28018487
[TBL] [Abstract][Full Text] [Related]
17. The Association between Abnormal Long Noncoding RNA MALAT-1 Expression and Cancer Lymph Node Metastasis: A Meta-Analysis.
Wang J; Pan Y; Wu J; Zhang C; Huang Y; Zhao R; Cheng G; Liu J; Qin C; Shao P; Hua L; Wang Z
Biomed Res Int; 2016; 2016():1823482. PubMed ID: 26989678
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MALAT1 as a putative biomarker of lymph node metastasis: a meta-analysis.
Zhai H; Chen QJ; Chen BD; Yang YN; Ma YT; Li XM; Liu F; Yu ZX; Xiang Y; Liao W; Lai HM
Int J Clin Exp Med; 2015; 8(5):7648-54. PubMed ID: 26221312
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer.
Tarabichi M; Saiselet M; Trésallet C; Hoang C; Larsimont D; Andry G; Maenhaut C; Detours V
Br J Cancer; 2015 May; 112(10):1665-74. PubMed ID: 25965298
[TBL] [Abstract][Full Text] [Related]
20. Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes.
Shriver CD; Hueman MT; Ellsworth RE
J Exp Clin Cancer Res; 2014 Dec; 33(1):116. PubMed ID: 25551369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
